Why we need to think about readiness for ALS

Why we need to think about readiness for ALS

ALS has a profound impact on people’s lives; new innovations are on the horizon, but it is important to consider how ready our health systems are to integrate new therapies.
Read More
Why we need readiness in NASH

Why we need readiness in NASH

Health systems need to be ready to respond to evolving evidence to ensure they can always deliver efficient and equitable care. The approval of a therapy would transform care for n
Read More
HPP launches framework to assess health system readiness

HPP launches framework to assess health system readiness

HPP is pleased to launch the Readiness Assessment Framework, which can be used to assess health system readiness for a number of different components of care.
Read More
When is the right time to think about health system readiness?

When is the right time to think about health system readiness?

Decision-makers must plan for the sustainable and timely integration of new technologies and processes into care.
Read More
How consistent terminology can aid integration of radioligand therapy

How consistent terminology can aid integration of radioligand therapy

Inconsistent use of terminology presents challenges to building awareness of radioligand therapy and appropriately integrating it into care.
Read More
The impact of COVID-19 highlights the need for innovative therapies in cancer care

The impact of COVID-19 highlights the need for innovative therapies in cancer care

COVID-19 has caused widespread disruption to cancer care. New approaches could provide more options for people with advanced, complex or metastatic cancers.
Read More
Call to share experiences of integrating radioligand therapy into care

Call to share experiences of integrating radioligand therapy into care

The Health Policy Partnership wants to better understand what actions and initiatives have taken place to improve the delivery of radioligand therapy.
Read More
World Theranostics Day 2022: what are theranostics and how can we use them?

World Theranostics Day 2022: what are theranostics and how can we use them?

On World Theranostics Day 2022, HPP explores the ongoing innovation and advancement in the field of theranostics.
Read More
We need continued research to ensure wider access to innovative therapies as soon as they are approved

We need continued research to ensure wider access to innovative therapies as soon as they are approved

In this guest blog, Dr Erik Briers emphasises the need for continued research and planning to make radioligand therapy a more viable treatment option.
Read More
SPARC-Europe highlights patient experience of radioligand therapy in new video

SPARC-Europe highlights patient experience of radioligand therapy in new video

SPARC-Europe has released a video of patient testimonies to raise awareness of the benefits of radioligand therapy and outline some of the challenges to access.
Read More
COVID-19 and health system readiness

COVID-19 and health system readiness

The COVID-19 pandemic has highlighted the importance of having a prepared and robust system that can keep day-to-day healthcare functions running.
Read More
New templates to aid application of the Radioligand Therapy Readiness Assessment Framework

New templates to aid application of the Radioligand Therapy Readiness Assessment Framework

The Health Policy Partnership has published a series of templates to support independent applications of the Radioligand Therapy Readiness Assessment Framework.
Read More